Lee & Man Chemical Company Limited (0746.HK)
HKD 3.67
(-1.61%)
HKD 3.67
(-1.61%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.22 Billion HKD | -14.83% |
| 2022 | 1.44 Billion HKD | -29.36% |
| 2021 | 2.04 Billion HKD | -12.51% |
| 2020 | 2.33 Billion HKD | 4.05% |
| 2019 | 2.24 Billion HKD | -12.87% |
| 2018 | 2.57 Billion HKD | -6.7% |
| 2017 | 2.76 Billion HKD | 14.56% |
| 2016 | 2.41 Billion HKD | 5.9% |
| 2015 | 2.27 Billion HKD | -5.81% |
| 2014 | 2.41 Billion HKD | 18.2% |
| 2013 | 2.04 Billion HKD | 27.88% |
| 2012 | 1.59 Billion HKD | 36.02% |
| 2011 | 1.17 Billion HKD | 33.65% |
| 2010 | 879.2 Million HKD | 28.04% |
| 2009 | 686.66 Million HKD | -8.23% |
| 2008 | 748.24 Million HKD | 100.49% |
| 2007 | 373.21 Million HKD | 267.53% |
| 2006 | 101.54 Million HKD | 0.0% |
| 2004 | 68.16 Million HKD | -48.21% |
| 2003 | 131.61 Million HKD | 20.34% |
| 2002 | 109.36 Million HKD | 36.83% |
| 2001 | 79.93 Million HKD | -39.39% |
| 2000 | 131.86 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.2 Billion HKD | 0.0% |
| 2023 Q4 | 1.22 Billion HKD | 0.0% |
| 2023 Q2 | 1.28 Billion HKD | 0.0% |
| 2023 FY | 1.22 Billion HKD | -14.83% |
| 2022 Q4 | 1.44 Billion HKD | 0.0% |
| 2022 Q2 | 1.41 Billion HKD | 0.0% |
| 2022 FY | 1.44 Billion HKD | -29.36% |
| 2021 FY | 2.04 Billion HKD | -12.51% |
| 2021 Q2 | 2.23 Billion HKD | 0.0% |
| 2021 Q4 | 2.04 Billion HKD | 0.0% |
| 2020 FY | 2.33 Billion HKD | 4.05% |
| 2020 Q2 | 2.11 Billion HKD | 0.0% |
| 2020 Q4 | 2.33 Billion HKD | 0.0% |
| 2019 Q4 | 2.24 Billion HKD | 0.0% |
| 2019 Q2 | 2.44 Billion HKD | 0.0% |
| 2019 FY | 2.24 Billion HKD | -12.87% |
| 2018 Q4 | 2.57 Billion HKD | 0.0% |
| 2018 Q2 | 2.68 Billion HKD | 0.0% |
| 2018 FY | 2.57 Billion HKD | -6.7% |
| 2017 Q2 | 2.71 Billion HKD | 0.0% |
| 2017 FY | 2.76 Billion HKD | 14.56% |
| 2017 Q4 | 2.76 Billion HKD | 0.0% |
| 2016 Q4 | 2.41 Billion HKD | 0.0% |
| 2016 FY | 2.41 Billion HKD | 5.9% |
| 2016 Q2 | 2.18 Billion HKD | 0.0% |
| 2015 Q4 | 2.27 Billion HKD | 0.0% |
| 2015 Q2 | 2.4 Billion HKD | 0.0% |
| 2015 FY | 2.27 Billion HKD | -5.81% |
| 2014 Q2 | 2.23 Billion HKD | 0.0% |
| 2014 Q4 | 2.41 Billion HKD | 0.0% |
| 2014 FY | 2.41 Billion HKD | 18.2% |
| 2013 Q4 | 2.04 Billion HKD | 0.0% |
| 2013 FY | 2.04 Billion HKD | 27.88% |
| 2013 Q2 | 1.95 Billion HKD | 0.0% |
| 2012 Q4 | 1.59 Billion HKD | 0.0% |
| 2012 Q3 | 1.59 Billion HKD | 0.47% |
| 2012 FY | 1.59 Billion HKD | 36.02% |
| 2012 Q2 | 1.59 Billion HKD | 0.0% |
| 2011 FY | 1.17 Billion HKD | 33.65% |
| 2011 Q2 | 756.31 Million HKD | 0.0% |
| 2011 Q4 | 1.17 Billion HKD | 0.0% |
| 2010 FY | 879.2 Million HKD | 28.04% |
| 2010 Q2 | 719.79 Million HKD | 0.0% |
| 2010 Q4 | 879.2 Million HKD | 0.0% |
| 2009 Q4 | 686.66 Million HKD | 0.0% |
| 2009 FY | 686.66 Million HKD | -8.23% |
| 2009 Q2 | 825.3 Million HKD | 0.0% |
| 2008 FY | 748.24 Million HKD | 100.49% |
| 2008 Q4 | 748.24 Million HKD | 0.0% |
| 2007 FY | 373.21 Million HKD | 267.53% |
| 2006 FY | 101.54 Million HKD | 0.0% |
| 2004 FY | 68.16 Million HKD | -48.21% |
| 2003 FY | 131.61 Million HKD | 20.34% |
| 2002 FY | 109.36 Million HKD | 36.83% |
| 2001 FY | 79.93 Million HKD | -39.39% |
| 2000 FY | 131.86 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 229.69 Million HKD | -435.157% |